India's National Stock Exchange filed for a $46 billion valuation IPO after receiving regulatory clearance, targeting a listing in the week of September 21. The Mumbai-based exchange operator, which handles 90% of India's equity derivatives volume and ranked first globally by contract count in 2024, trimmed its initial valuation ask from north of $50 billion following feedback from anchor investors during pre-marketing.
The offering will comprise a secondary sale of existing shares with no primary capital raise, according to three people with direct knowledge of the filing. NSE's largest shareholders — including a consortium of domestic banks and foreign institutional investors who acquired stakes during the exchange's 2016 de-mutualization — are selling down positions ahead of anticipated regulatory changes requiring broader public float for systemically important market infrastructure. The Securities and Exchange Board of India granted final approval for the prospectus on Thursday, clearing the path for roadshow presentations to begin Monday across Singapore, Hong Kong, and London ahead of domestic institutional pre-IPO phases.
The $46 billion print would make NSE the third-most-valuable exchange operator globally by market capitalization, behind only CME Group at $93 billion and Nasdaq at $48 billion, and nearly double Intercontinental Exchange's current $97 billion enterprise value when adjusted for net debt. More precisely, it positions the venue at 3.2x the combined market cap of both BSE Ltd and Multi Commodity Exchange of India, the country's next two largest organized trading platforms. NSE processed an average daily notional value of $180 billion in equity derivatives during Q2 2025, up 41% year-over-year, driven primarily by retail participation in index options. Cash equity volumes remained flat at $12 billion daily, but derivatives revenue now accounts for 73% of total exchange income versus 54% three years prior.
The valuation multiple implies 18.4x trailing twelve-month EBITDA based on the exchange's most recent disclosed financials, a premium to Hong Kong Exchanges and Clearing at 15.1x but below Singapore Exchange's 22.7x. The discount to SGX reflects two structural factors: NSE's revenue concentration in a single product class, and persistent regulatory overhang from a 2022 co-location controversy that resulted in leadership changes and delayed the IPO by nearly thirty months. The exchange has since implemented new surveillance protocols and appointed external compliance monitors, but institutional investors continue to price in a 15-20% discount for governance risk relative to peers with cleaner operational histories.
Operators should track three specific developments through October. First, anchor investor allocation announcements scheduled for September 18 will reveal whether sovereign wealth funds and pension systems treat this as strategic infrastructure exposure or purely tactical beta. Second, the retail subscription window opening September 19 will test whether domestic participation mirrors the 170x oversubscription seen in recent fintech IPOs or reflects more conservative appetite given the secondary-only structure. Third, NSE's post-listing lock-up schedule — reportedly staggered across 6, 12, and 18 months for different shareholder classes — will determine available float and price stability through mid-2026.
The exchange has already lined up $8.2 billion in cornerstone commitments from six large allocators, none named publicly but described by two banking sources as a mix of Asian sovereign vehicles and US endowments seeking India equity market exposure without direct portfolio construction. That figure represents 17.8% of the total deal size, above the 12-15% anchor threshold typical for Indian primary offerings but below the 25% level that would signal distribution concerns.